文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

预防性给予nCMT-3可减轻脓毒症诱导的急性肾损伤,该作用与NLRP3炎症小体激活及细胞凋亡相关

PROPHYLACTIC n CMT-3 ATTENUATES SEPSIS-INDUCED ACUTE KIDNEY INJURY IN ASSOCIATION WITH NLRP3 INFLAMMASOME ACTIVATION AND APOPTOSIS.
PubMed 文献 · Shock · 2023-03-21
一句话结论小鼠实验中,预防性雾化吸入nCMT-3(1 mg/kg)可减轻气管内LPS诱导的急性肾损伤、炎症与凋亡,机制涉及抑制肾脏NLRP3炎症小体激活。

该研究在C57BL/6小鼠中经气管内给予LPS(2.5 mg/kg)诱导急性肺损伤相关急性肾损伤,并在LPS前给予雾化吸入nCMT-3(1 mg/kg)或生理盐水,24 h取材。LPS组出现血尿素氮、肌酐及肾损伤标志物(中性粒细胞明胶酶相关脂质运载蛋白、肾损伤分子1)升高和组织学肾损伤,同时IL-1β、IL-6、活性MMP-2/MMP-9、促凋亡蛋白、凋亡细胞、NLRP3、caspase-1及p38信号升高。气管内nCMT-3显著减轻上述所有肾损伤、炎症和凋亡指标。作者结论为预防性雾化nCMT-3通过抑制肾脏NLRP3炎症小体激活、肾脏炎症和凋亡减轻LPS诱导的AKI。

要点

  • C57BL/6小鼠经气管内LPS(2.5 mg/kg)诱导急性肺损伤相关AKI,24 h可见血尿素氮、肌酐及NGAL、KIM-1升高和组织学肾损伤。
  • 预防性雾化吸入nCMT-3(1 mg/kg)显著减轻LPS诱导的全部肾损伤标志物、炎症和凋亡指标。
  • LPS组肾脏IL-1β、IL-6、活性MMP-2和MMP-9、NLRP3、caspase-1及p38信号均升高,nCMT-3可减轻这些改变。
  • 该研究为动物实验,nCMT-3为预防性给药,不能据此直接转化为脓毒症AKI的临床用药推荐。

适用人群与场景

  • C57BL/6小鼠,经气管内LPS(2.5 mg/kg)诱导急性肺损伤相关急性肾损伤模型。

处置流程与药物剂量

  • 预防性雾化吸入nCMT-3 1 mg/kg(气管内给药),随后经气管内给予LPS 2.5 mg/kg,24 h后取材检测。

研究设计与关键结果

  • 研究类型为动物实验;C57BL/6小鼠接受雾化气管内nCMT-3(1 mg/kg)或生理盐水,随后气管内LPS(2.5 mg/kg)诱导急性肺损伤相关AKI,24 h取材。
  • LPS诱导的AKI表现为血浆血尿素氮、肌酐、损伤生物标志物(中性粒细胞明胶酶相关脂质运载蛋白、肾损伤分子1)升高及肾脏损伤的组织学证据。
  • LPS处理小鼠肾脏炎症细胞因子(IL-1β、IL-6)、活性MMP-2和MMP-9、促凋亡蛋白(细胞色素C、Bax/Bcl-2比值、cleaved caspase-3)、凋亡细胞、炎症小体激活(NLRP3、caspase-1)及p38信号均升高。
  • 气管内nCMT-3显著减轻所有测定的肾损伤、炎症和凋亡标志物。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,预防性雾化nCMT-3通过抑制肾脏NLRP3炎症小体激活、肾脏炎症和凋亡减轻LPS诱导的AKI。
  • 原文为小鼠预防性给药研究,未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: The kidney is the most common extrapulmonary organ injured in sepsis. The current study examines the ability of aerosolized nanochemically modified tetracycline 3 (nCMT-3), a pleiotropic anti-inflammatory agent, to attenuate acute kidney injury (AKI) caused by intratracheal LPS. Methods: C57BL/6 mice received aerosolized intratracheal nCMT-3 (1 mg/kg) or saline, followed by intratracheal LPS (2.5 mg/kg) to induce acute lung injury-induced AKI. Tissues were harvested at 24 h. The effects of nCMT-3 and LPS on AKI were assessed by plasma/tissue levels of serum urea nitrogen, creatinine, neutrophil gelatinase-associated lipocalin, kidney injury molecule 1, and renal histology. Renal matrix metalloproteinase (MMP) level/activity, cytochrome C, Bax, Bcl-2, caspase-3, p38 mitogen-activated protein kinase activation, NLRP3, and caspase-1 were also measured. Apoptotic cells in kidney were determined by TUNEL assay. Renal levels of IL-1β and IL-6 were measured to assess inflammation. Results: Acute lung injury-induced AKI was characterized by increased plasma blood urea nitrogen, creatinine, injury biomarkers (neutrophil gelatinase-associated lipocalin, kidney injury molecule 1), and histologic evidence of renal injury. Lipopolysaccharide-treated mice demonstrated renal injury with increased levels of inflammatory cytokines (IL-1β, IL-6), active MMP-2 and MMP-9, proapoptotic proteins (cytochrome C, Bax/Bcl-2 ratio, cleaved caspase-3), apoptotic cells, inflammasome activation (NLRP3, caspase-1), and p38 signaling. Intratracheal nCMT-3 significantly attenuated all the measured markers of renal injury, inflammation, and apoptosis. Conclusions: Pretreatment with aerosolized nCMT-3 attenuates LPS-induced AKI by inhibiting renal NLRP3 inflammasome activation, renal inflammation, and apoptosis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Ma J, Wang X, Gu R, et al. PROPHYLACTIC n CMT-3 ATTENUATES SEPSIS-INDUCED ACUTE KIDNEY INJURY IN ASSOCIATION WITH NLRP3 INFLAMMASOME ACTIVATION AND APOPTOSIS. Shock. 2023. PMID: 36939682. doi:10.1097/SHK.0000000000002118

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。